Stereochemical aspects of MAO interactions: reversible and selective inhibitors of monoamine oxidase
- 31 December 1985
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 6, 246-251
- https://doi.org/10.1016/0165-6147(85)90116-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Selective inhibitors of monoamine oxidase A and B: Biochemical, pharmacological, and clinical propertiesMedicinal Research Reviews, 1984
- Metabolism of the monoamine oxidase-B inhibitor, MD 780236 and its enantiomers by the A and B forms of the enzyme in the ratJournal of Pharmacy and Pharmacology, 1983
- Different stereoselective inhibition of monoamine oxidase-B by the R- and S-enantiomers of MD 780236Journal of Pharmacy and Pharmacology, 1983
- Substrate- and stereoselective inhibition of human brain monoamine oxidase by 4-dimethylamino-α, 2-dimethylphenethylamine (FLA 336)Journal of Pharmacy and Pharmacology, 1981
- Characteristics of the Inhibition of Rat Brain Monoamine Oxidase In Vitro by MD780515Journal of Neurochemistry, 1981
- The effect of lipophilic compounds upon the activity of rat liver mitochondrial monoamine oxidase-A and -BBiochemical Pharmacology, 1980
- Monoamine oxidase inhibition and brain amine metabolism after oral treatment with toloxatone in the ratJournal of Pharmacy and Pharmacology, 1979
- Inhibition of monoamine oxidase by amphetamine and related compoundsBiochemical Pharmacology, 1976
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968
- Clinical Trial of the Treatment of Depressive IllnessBMJ, 1965